PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.10%
Positive revenue growth while ENPH is negative. John Neff might see a notable competitive edge here.
15.31%
Positive gross profit growth while ENPH is negative. John Neff would see a clear operational edge over the competitor.
44.28%
EBIT growth above 1.5x ENPH's 1.58%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
23.57%
Operating income growth above 1.5x ENPH's 1.58%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
42.88%
Net income growth above 1.5x ENPH's 7.03%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
34.48%
EPS growth above 1.5x ENPH's 7.48%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
34.48%
Diluted EPS growth above 1.5x ENPH's 6.86%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.29%
Slight or no buybacks while ENPH is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
0.29%
Slight or no buyback while ENPH is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
87.22%
OCF growth above 1.5x ENPH's 9.35%. David Dodd would confirm a clear edge in underlying cash generation.
77.66%
FCF growth above 1.5x ENPH's 0.66%. David Dodd would verify if the firm’s strategic investments yield superior returns.
-44.47%
Negative 10Y revenue/share CAGR while ENPH stands at 272.45%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-16.93%
Negative 5Y CAGR while ENPH stands at 540.96%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
27.52%
3Y revenue/share CAGR under 50% of ENPH's 416.08%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
81.97%
10Y OCF/share CAGR under 50% of ENPH's 8385.28%. Michael Burry would worry about a persistent underperformance in cash creation.
88.61%
Below 50% of ENPH's 4414.30%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-181.21%
Negative 3Y OCF/share CAGR while ENPH stands at 864.56%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-210.21%
Negative 10Y net income/share CAGR while ENPH is at 848.72%. Joel Greenblatt sees a major red flag in long-term profit erosion.
94.38%
Below 50% of ENPH's 2976.70%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-256.41%
Negative 3Y CAGR while ENPH is 402.81%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
-65.63%
Negative equity/share CAGR over 10 years while ENPH stands at 568.13%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
1001.41%
Below 50% of ENPH's 2309.29%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
1362.76%
3Y equity/share CAGR above 1.5x ENPH's 139.37%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.28%
AR growth well above ENPH's 0.81%. Michael Burry fears inflated revenue or higher default risk in the near future.
11.05%
Inventory growth well above ENPH's 10.33%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
5.45%
Asset growth above 1.5x ENPH's 2.52%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-5.37%
We have a declining book value while ENPH shows 0.32%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
22.31%
Debt growth far above ENPH's 0.16%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-10.20%
Our R&D shrinks while ENPH invests at 5.10%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-8.99%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.